Cargando…
Virtual Screening for Potential Allosteric Inhibitors of Cyclin-Dependent Kinase 2 from Traditional Chinese Medicine
Cyclin-dependent kinase 2 (CDK2), a member of Cyclin-dependent kinases (CDKs), plays an important role in cell division and DNA replication. It is regarded as a desired target to treat cancer and tumor by interrupting aberrant cell proliferation. Compared to lower subtype selectivity of CDK2 ATP-com...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274045/ https://www.ncbi.nlm.nih.gov/pubmed/27657032 http://dx.doi.org/10.3390/molecules21091259 |
_version_ | 1783377527766515712 |
---|---|
author | Lu, Fang Luo, Ganggang Qiao, Liansheng Jiang, Ludi Li, Gongyu Zhang, Yanling |
author_facet | Lu, Fang Luo, Ganggang Qiao, Liansheng Jiang, Ludi Li, Gongyu Zhang, Yanling |
author_sort | Lu, Fang |
collection | PubMed |
description | Cyclin-dependent kinase 2 (CDK2), a member of Cyclin-dependent kinases (CDKs), plays an important role in cell division and DNA replication. It is regarded as a desired target to treat cancer and tumor by interrupting aberrant cell proliferation. Compared to lower subtype selectivity of CDK2 ATP-competitive inhibitors, CDK2 allosteric inhibitor with higher subtype selectivity has been used to treat CDK2-related diseases. Recently, the first crystal structure of CDK2 with allosteric inhibitor has been reported, which provides new opportunities to design pure allosteric inhibitors of CDK2. The binding site of the ATP-competition inhibitors and the allosteric inhibitors are partially overlapped in space position, so the same compound might interact with the two binding sites. Thus a novel screening strategy was essential for the discovery of pure CDK2 allosteric inhibitors. In this study, pharmacophore and molecular docking were used to screen potential CDK2 allosteric inhibitors and ATP-competition inhibitors from Traditional Chinese Medicine (TCM). In the docking result of the allosteric site, the compounds which can act with the CDK2 ATP site were discarded, and the remaining compounds were regarded as the potential pure allosteric inhibitors. Among the results, prostaglandin E1 and nordihydroguaiaretic acid (NDGA) were available and their growth inhibitory effect on human HepG2 cell lines was determined by MTT assay. The two compounds could substantially inhibit the growth of HepG2 cell lines with an estimated IC(50) of 41.223 μmol/L and 45.646 μmol/L. This study provides virtual screening strategy of allosteric compounds and a reliable method to discover potential pure CDK2 allosteric inhibitors from TCM. Prostaglandin E1 and NDGA could be regarded as promising candidates for CDK2 allosteric inhibitors. |
format | Online Article Text |
id | pubmed-6274045 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62740452018-12-28 Virtual Screening for Potential Allosteric Inhibitors of Cyclin-Dependent Kinase 2 from Traditional Chinese Medicine Lu, Fang Luo, Ganggang Qiao, Liansheng Jiang, Ludi Li, Gongyu Zhang, Yanling Molecules Article Cyclin-dependent kinase 2 (CDK2), a member of Cyclin-dependent kinases (CDKs), plays an important role in cell division and DNA replication. It is regarded as a desired target to treat cancer and tumor by interrupting aberrant cell proliferation. Compared to lower subtype selectivity of CDK2 ATP-competitive inhibitors, CDK2 allosteric inhibitor with higher subtype selectivity has been used to treat CDK2-related diseases. Recently, the first crystal structure of CDK2 with allosteric inhibitor has been reported, which provides new opportunities to design pure allosteric inhibitors of CDK2. The binding site of the ATP-competition inhibitors and the allosteric inhibitors are partially overlapped in space position, so the same compound might interact with the two binding sites. Thus a novel screening strategy was essential for the discovery of pure CDK2 allosteric inhibitors. In this study, pharmacophore and molecular docking were used to screen potential CDK2 allosteric inhibitors and ATP-competition inhibitors from Traditional Chinese Medicine (TCM). In the docking result of the allosteric site, the compounds which can act with the CDK2 ATP site were discarded, and the remaining compounds were regarded as the potential pure allosteric inhibitors. Among the results, prostaglandin E1 and nordihydroguaiaretic acid (NDGA) were available and their growth inhibitory effect on human HepG2 cell lines was determined by MTT assay. The two compounds could substantially inhibit the growth of HepG2 cell lines with an estimated IC(50) of 41.223 μmol/L and 45.646 μmol/L. This study provides virtual screening strategy of allosteric compounds and a reliable method to discover potential pure CDK2 allosteric inhibitors from TCM. Prostaglandin E1 and NDGA could be regarded as promising candidates for CDK2 allosteric inhibitors. MDPI 2016-09-21 /pmc/articles/PMC6274045/ /pubmed/27657032 http://dx.doi.org/10.3390/molecules21091259 Text en © 2016 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lu, Fang Luo, Ganggang Qiao, Liansheng Jiang, Ludi Li, Gongyu Zhang, Yanling Virtual Screening for Potential Allosteric Inhibitors of Cyclin-Dependent Kinase 2 from Traditional Chinese Medicine |
title | Virtual Screening for Potential Allosteric Inhibitors of Cyclin-Dependent Kinase 2 from Traditional Chinese Medicine |
title_full | Virtual Screening for Potential Allosteric Inhibitors of Cyclin-Dependent Kinase 2 from Traditional Chinese Medicine |
title_fullStr | Virtual Screening for Potential Allosteric Inhibitors of Cyclin-Dependent Kinase 2 from Traditional Chinese Medicine |
title_full_unstemmed | Virtual Screening for Potential Allosteric Inhibitors of Cyclin-Dependent Kinase 2 from Traditional Chinese Medicine |
title_short | Virtual Screening for Potential Allosteric Inhibitors of Cyclin-Dependent Kinase 2 from Traditional Chinese Medicine |
title_sort | virtual screening for potential allosteric inhibitors of cyclin-dependent kinase 2 from traditional chinese medicine |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274045/ https://www.ncbi.nlm.nih.gov/pubmed/27657032 http://dx.doi.org/10.3390/molecules21091259 |
work_keys_str_mv | AT lufang virtualscreeningforpotentialallostericinhibitorsofcyclindependentkinase2fromtraditionalchinesemedicine AT luoganggang virtualscreeningforpotentialallostericinhibitorsofcyclindependentkinase2fromtraditionalchinesemedicine AT qiaoliansheng virtualscreeningforpotentialallostericinhibitorsofcyclindependentkinase2fromtraditionalchinesemedicine AT jiangludi virtualscreeningforpotentialallostericinhibitorsofcyclindependentkinase2fromtraditionalchinesemedicine AT ligongyu virtualscreeningforpotentialallostericinhibitorsofcyclindependentkinase2fromtraditionalchinesemedicine AT zhangyanling virtualscreeningforpotentialallostericinhibitorsofcyclindependentkinase2fromtraditionalchinesemedicine |